1Department of Hematology-Oncology, Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Clin Appl Thromb Hemost. 2014 May;20(4):349-54. doi: 10.1177/1076029613513319. Epub 2013 Nov 27.
Enzyme-linked immunosorbent assay (ELISA) for antiplatelet factor 4 (anti-PF4)/heparin antibodies is expressed in terms of optical density (OD). Previous studies have shown correlation between OD and heparin-induced thrombocytopenia (HIT) diagnosis. However, these were mainly laboratory based.
Retrospective correlation of clinical HIT to ELISA OD.
PATIENTS/METHODS: We conducted a retrospective study involving 104 patients with a positive ELISA for anti-PF4/heparin antibodies between 2008 and May 2012. For each patient, a clinical diagnosis was adjudicated based on different features including "4T scores," laboratory results, and a 3-month clinical follow-up.
In this study, 28.8% of the patients were HIT positive, and 71.2% HIT negative. Patients with positive diagnosis had significantly higher mean OD (2.15 ± 0.76 vs 0.83 ± 0.62). Patients with OD <1.0 only had 3.4% positive diagnosis versus 45.5% for OD 1.0 to 2.0 and 78% for >2.0 units.
This study is a clinical confirmation that ELISA OD results are correlated with the probability of a clinical diagnosis of HIT.
酶联免疫吸附测定(ELISA)检测抗血小板因子 4(抗-PF4)/肝素抗体的结果以光密度(OD)表示。先前的研究表明 OD 与肝素诱导的血小板减少症(HIT)的诊断相关。然而,这些研究主要是基于实验室的。
将临床 HIT 与 ELISA OD 进行回顾性相关性分析。
患者/方法:我们进行了一项回顾性研究,纳入了 2008 年至 2012 年 5 月间 104 例 ELISA 抗-PF4/肝素抗体阳性的患者。根据不同特征(包括“4T 评分”、实验室结果和 3 个月的临床随访),对每位患者的临床诊断进行了判定。
在这项研究中,28.8%的患者 HIT 阳性,71.2% HIT 阴性。阳性诊断的患者 OD 值明显更高(2.15 ± 0.76 对 0.83 ± 0.62)。OD 值<1.0 的患者阳性诊断率仅为 3.4%,而 OD 值为 1.0-2.0 的患者阳性诊断率为 45.5%,OD 值>2.0 的患者阳性诊断率为 78%。
这项研究临床证实了 ELISA OD 值结果与 HIT 临床诊断的可能性相关。